Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor

Cancer and Metastasis Reviews

Volumn 15, Issue 2, 1996, Pages 177-186

  Vlodavsky, Israel ^a   Miao, Hua Quan ^a   Medalion, Benjamin ^a   Danagher, Pamela ^b   Ron, Dina ^c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b IBEX Technologies   (Canada)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Extracellular matrix; FGF receptor binding; Heparin sulfate degrading enzymes; Heparin mimicking compounds

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; GLUCOSAMINE; HEPARAN SULFATE; HEXURONIC ACID; LAMININ;

ANGIOGENESIS; CELL SURFACE; CONFORMATIONAL TRANSITION; DIMERIZATION; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; SULFATION;

ANIMALS; CELL DIVISION; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; HEPARIN; HEPARITIN SULFATE; HUMANS; PROTEOGLYCANS;

EID: 0030018209     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00437470     Document Type: Review

References (57)

1. Kjellen L, Lindahl U: Proteoglycans: structures and interactions. Ann Rev Biochem 60: 443-475, 1991
2. Jackson RL, Busch SJ, Cardin AD: Glycosaminoglycans: molecular properties, protein interactions and role in physiological processes. Physiol Rev 71: 481-539, 1991
3. Ruoslahti E, Yamaguchi Y: Proteoglycans as modulators of growth factor activities. Cell 64: 867-869, 1991
4. Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z: Extracellular matrix-bound growth factors, enzymes and plasma proteins. In: Rohrbach DH, Timple R (eds) Basement Membranes: Cellular and Molecular Aspects. Academic Press Inc., Orlando, Fl. 1993, pp 327-343
5. Folkman J, Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1987
6. Saksela O, Moscatelli D, Sommer A, Rifkin DB: Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107: 743-751, 1988
7. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848, 1991
8. Folkman J, Shing Y: Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313: 355-364, 1992
9. Azizkhan R, Azizkhan J, Zetter B, Folkman J: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 152: 931-944, 1980
10. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M: Heparin-affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223: 1296-1298, 1984
11. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992
12. Thornton SC, Mueller SN, Levine EM: Human endothelial cells: use of heparin in cloning and long term serial cultivation. Science 222: 623-62, 1983
13. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475-484, 1986
14. Rapraeger A: In the clutches of proteoglycans: how does heparan sulfate regulate FGF binding. Curr Biol 2: 645-649, 1995
15. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaelli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84: 2292-2296, 1987
16. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 130: 393-400, 1980
17. Fedarko N, Conrad E: A unique heparin sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J Cell Biol 102: 587-599, 1986
18. Crum R, Szabo S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378, 1985
19. Cardon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, Hicklin D, Fuks Z: Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 63: 832-840, 1990
20. Gonzalez AM, Buscaglia M, Ong M, Baird A: Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 110: 753-765, 1990
21. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I: Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28: 1737-1743, 1989
22. Hanneken A, Maher PA, Baird A: High affinity immuno-reactive FGF receptors in the extracellular matrix of vascular endothelial cells - implications for the modulation of FGF-2. J Cell Biol 128: 1221-1228, 1995
23. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fukz Z: Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 16: 268-271, 1991
24. Ishai-Michaeli R, Svaln C-M, Chajek-Shaul T, Korner G, Ekre H-P, Vlodavsky I: Importance of size and sulfation of heparin in release of basic fibroblast factor from the vascular endothelium and extracellular matrix. Biochemistry 31: 2080-2088, 1992
25. Miao H-O, Ishai-Michaeli R, Atzmon R, Peretz T, Vlodavsky I: Sulfate moieties in the subendothelial extracellular matrix are involved in bFGF sequestration, dimerization and stimulation of cell proliferation. J Biol Chem 271: 4879-4886, 1996
26. Brunner G, Gabrilove J, Rifkin DB, Wilson EL: Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan. J Cell Biol 114: 1275-1283, 1991
27. Bashkin P, Neufeld G, Gitay GH, Vlodavsky I: Release of cell surface-associated basic fibroblast growth factor by glycosylphosphatidylinositol-specific phospholipase C. J Cell Physiol 151: 126-137, 1992
28. Thompson RW, Whales GF, Saunders KB, Hores T, D'Amore P: Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. Growth Factors 3: 221-229, 1990
29. Ishai-Michaeli R, Eldor A, Vlodavsky I: Heparanase activity expressed by platelets, neutrophils and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Reg 1: 833-842, 1990
30. Benezra M, Vlodavsky I, Ishai MR, Neufeld G, Bar-Shavit R: Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 81: 3324-3331, 1993
31. Saksela O, Rifkin DB: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 110: 767-775, 1990
32. Roberts R, Gallagher J, Spooncer S, Allen TD, Bloomfield F, Dexter TM: Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332: 376-378, 1988
33. Tanaka Y, Adams DH, Shaw S: Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytes. Immunol Today 14: 111-115, 1993
34. Hoogewerf AJ, Leone JW, Reardon M, Howe WJ, Asa D, Heinrikson RL, Ledhetter SR: CXC chemokines connective tissue activation peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes. J Biol Chem 270: 3268-3277, 1995
35. Gilat D, Hershkoviz R, Goldkorn I, Cahalon L, Korner G, Vlodavsky I, Lider O: Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH. J Exp Med 181: 1929-1934, 1995
36. Roghani M, Moscatelli D: Basic fihrohlast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 267: 22156-22162, 1992
37. Bernfield M, Hooper KC: Possible regulation of FGF activity by syndecan, an integral membrane heparan sulfate proteoglycan. Ann NY Acad Sci 638: 182-194, 1991
38. Guimond S, Maccarana M, Olwin BB, Lindahl U, Rapraeger AC: Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J Biol Chem 268: 23906-23914, 1993
39. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P: Heparin is required for cell-free binding of bFGF to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12: 240-247, 1992
40. Schlessinger J, Lax I, Lemmon M: Regulation of growth factor activation by proteoglycans: what is the role of the lowaffinity receptors? Cell 83: 357-360, 1995
41. Miao H-Q, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I: Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem 57: 173-184, 1995
42. Roghani M, Mansukhani A, Dell'Era P, Bellosta P, Basilico C, Rifkin DB, Moscatelli D: Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J Biol Chem 269: 3976-3984, 1994
43. Caccia P, Cletini O, Isacchi A, Bergonozoni L, Orsini G: Biochemical characterization of the molecular interaction between recombinant basic fibroblast growth factor and a recombinant soluble fibroblast growth factor receptor. Biochem J 294: 639-644, 1993
44. Pantoliano MW, Horlick RA, Springer BA, Van Dyke DE, Tobery T, Wetmore DR, Lear JD, Nahapetian AT, Bradley JD, Sisk WP: Multivalent ligand-receptor interactions in fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry 33: 10229-10248, 1994
45. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I: Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79: 1015-1024, 1994
46. Moscatelli D: Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem 267: 25803-25809, 1992
47. Gitay-Goren H, Cohen T, Tessler S, Soker S, Gengrinovitch S, Rockwell P, Klagshrun M, Levi B-Z, Neufeld G: Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. Biochem J 271: 5519-5523, 1996
48. Kan M, Wang F, Xu J, Crabb JW, Hon J, Mckeehan WL: An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259: 1918-1921, 1993
49. de Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor; Crystal structure of the complex. Science 255: 306-312, 1992
50. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, Langer R: Heparinase inhibits neovascularization. Proc Natl Acad Sci USA 91: 1524-1528, 1994
51. Reich-Slotky R, Shaoul E, Berman B, Graziani G, Ron D: Chimeric molecules between keratinocyte growth factor and basic fibroblast growth factor define domains that confer receptor binding specificities. J Biol Chem 270: 29813-29818, 1995
52. Aviezer D, Levy E, Safran M, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I, Yayon A: Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269: 114-121, 1994
53. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A: Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79: 1005-1013, 1994
54. Reich-Slotky R, Bonneh-Barkay D, Shaoul E, Bluma B, Svahn CM, Ron D: Differential effect of cell-associated heparan sulfates on the binding of keratinocyte growth factor (KGF) and acidic fibroblast growth factor to the KGF receptor. J Biol Chem 269: 32279-32285, 1994
55. Benezra M, Vlodavsky I, Yayon A, Bar-Shavit R, Regan J, Chang M, Ben SS: Reversal of basic fibroblast growth factor-mediated autocrine cell transformation by aromatic anionic compounds. Cancer Res 52: 5656-5662, 1992
56. Benezra M, Ben-Sasson S, Regan J, Chang M, Bar-Shavit R, Vlodavsky I: Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arterioscler Thromb 14: 1992-1999, 1994
57. Vlodavsky I, Miao HQ, Atzmon R, Levi E, Zimmermann J, Bar-Shavit R, Peretz T, Ben-Sasson S: Control of cell proliferation by heparan sulfate and heparin-binding growth factors. Thromb Haemost 74: 534-540, 1995